Northwestern Kellogg logo

Take Action

Home | Faculty & Research Overview | Research

Research Details

Genzyme: The Synvisc-One Investment Decision

Abstract

Executives at biotechnology firm Genzyme are debating funding a clinical trial for a new version of a medical device called Synvisc. The trial is expensive and the odds of success are not high, but the upside is substantial. The case presents a common business question: invest or not? The case forces students to think about customer insights, wrestle with a number of complex issues, and evaluate the financials of the decision.

Type

Case

Author(s)

Timothy Calkins, Ann Deming

Date Published

02/05/2010

Citations

Calkins, Timothy, and Ann Deming. Genzyme: The Synvisc-One Investment Decision. Case 5-110-001 (KEL439).

PREVIEW or BUY
KELLOGG INSIGHT

Explore leading research and ideas

Find articles, podcast episodes, and videos that spark ideas in lifelong learners, and inspire those looking to advance in their careers.
learn more

COURSE CATALOG

Review Courses & Schedules

Access information about specific courses and their schedules by viewing the interactive course scheduler tool.
LEARN MORE

DEGREE PROGRAMS

Discover the path to your goals

Whether you choose our Full-Time, Part-Time or Executive MBA program, you’ll enjoy the same unparalleled education, exceptional faculty and distinctive culture.
learn more